Cyclin D1 expression in KRAS mutant non-small cell lung cancer-old wine into new skins

被引：6
|
作者：
Goh, Kah Yee [1 ]
Lim, Wan-Teck [1 ,2 ,3 ]
机构：
[1] Natl Canc Ctr Singapore, Div Med Oncol, 11 Hosp Dr, Singapore, Singapore
[2] Duke NUS Med Sch, Off Acad & Clin Dev, Singapore, Singapore
[3] ASTAR, Inst Mol & Cell Biol, Proteos, Singapore
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2020年 / 9卷 / 06期
基金：
英国医学研究理事会;
关键词：
MUTATION; CARCINOMA;
D O I：
10.21037/tlcr-20-639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2302 / 2304
页数：3
相关论文
共 50 条
  • [31] The role of EphA2 in KRAS mutant non-small cell lung cancer
    Amato, Katherine
    Wang, Shan
    Hastings, Andrew
    Chen, Haiying
    Colvin, Daniel
    Ye, Fei
    Chen, Jin
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [32] Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
    Aredo, J.
    Padda, S.
    Kunder, C.
    Han, S.
    Wakelee, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1133 - S1133
  • [33] Molecular mechanisms driving oncogenesis in KRAS mutant non-small cell lung cancer
    Holderfield, Matthew
    McCormick, Frank
    Nagel, Tobi
    CANCER RESEARCH, 2010, 70
  • [34] Molecular Characterization and Prognosis of Patients with KRAS Mutant Non-small Cell Lung Cancer
    Gutierrez Sainz, L.
    Villamayor, J.
    Higuera, O.
    Cruz Castellanos, P.
    Vinal Lozano, D.
    Esteban Rodriguez, I.
    Regojo, R. M.
    Pelaez Garcia, A.
    Heredia Soto, V.
    Mendiola, M.
    Rosas Alonso, R.
    Rodriguez Antolin, C.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S620 - S621
  • [35] KRAS-Mutant non-small cell lung cancer: From biology to therapy
    Ferrer, Irene
    Zugazagoitia, Jon
    Herbertz, Stephan
    John, William
    Paz-Ares, Luis
    Schmid-Bindert, Gerald
    LUNG CANCER, 2018, 124 : 53 - 64
  • [36] A role of nicotinamide phosphoribosyltransferase in growth of KRAS mutant non-small cell lung cancer
    Okumura, Shunsuke
    Sasaki, Takaaki
    Ohsaki, Yoshinobu
    CANCER RESEARCH, 2015, 75
  • [37] Mutant KRAS decouples glycolysis from cell mechanics in non-small cell lung cancer
    Park, Jin Suk
    Sudderth, Jessica
    Gao, Boning
    Bachoo, Robert
    Danuser, Gaudenz
    CANCER RESEARCH, 2017, 77
  • [38] Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
    Zhang, Jun
    Park, Dongkyoo
    Shin, Dong M.
    Deng, Xingming
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 11 - 16
  • [39] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [40] Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer
    Ko, Eunkyung
    Kim, Yujin
    Park, Seong-Eun
    Cho, Eun Yoon
    Han, Jungho
    Shim, Young Mog
    Park, Joobae
    Kim, Duk-Hwan
    LUNG CANCER, 2012, 77 (02) : 401 - 406
12345